DMAA short interest
Drugs Made In America Acquisition Corp. Ordinary Shares · Financial Services · Shell Companies · settlement date 2026-09-30
| Shares short | 89,787 |
|---|---|
| Change vs prior report | -2,736 (-3.0%) |
| Change over six months | +420.4% |
| Days to cover | 101.00 (sector: 2.70) |
| Average daily volume | 889 |
| Rank in Financial Services | not ranked (OTC, fund or thinly traded) |
DMAA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 89,787 | -3.0% | 101.00 | 889 |
| 2026-09-15 | 92,523 | +16.5% | 1.31 | 70,510 |
| 2026-08-31 | 79,392 | -1.5% | 5.04 | 15,749 |
| 2026-08-14 | 80,595 | -9.1% | 155.89 | 517 |
| 2026-07-31 | 88,655 | -5.6% | 5.10 | 17,395 |
| 2026-07-15 | 93,894 | +13.1% | 1.56 | 60,138 |
| 2026-06-30 | 82,989 | +8.4% | 2.31 | 35,869 |
| 2026-06-15 | 76,532 | -12.0% | 2.12 | 36,048 |
| 2026-05-29 | 86,950 | -9.9% | 1.49 | 58,516 |
| 2026-05-15 | 96,507 | -7.0% | 13.07 | 7,384 |
| 2026-04-30 | 103,808 | -92.9% | 1.00 | 163,128 |
| 2026-04-15 | 1,465,993 | +8397.5% | 4.01 | 365,632 |
| 2026-03-31 | 17,252 | -30.6% | 1.00 | 43,602 |
| 2026-03-13 | 24,866 | -11.9% | 1.00 | 167,838 |
| 2026-02-27 | 28,215 | -0.8% | 1.00 | 80,235 |
| 2026-02-13 | 28,441 | -21.7% | 1.00 | 97,943 |
| 2026-01-30 | 36,307 | -6.1% | 2.47 | 14,670 |
| 2026-01-15 | 38,664 | -2.1% | 8.32 | 4,647 |
| 2025-12-31 | 39,485 | -5.9% | 4.90 | 8,057 |
| 2025-12-15 | 41,977 | -11.8% | 3.24 | 12,951 |
| 2025-11-28 | 47,591 | -11.7% | 8.13 | 5,854 |
| 2025-11-14 | 53,913 | -3.8% | 1.82 | 29,681 |
| 2025-10-31 | 56,039 | +8.1% | 2.22 | 25,205 |
| 2025-10-15 | 51,840 | +3.3% | 1.17 | 44,175 |
| 2025-09-30 | 50,181 | -1.3% | 1.00 | 78,349 |
import finzdata as yf
yf.Ticker("DMAA").short_interest # every report since 2017
yf.Client().short_interest(["DMAA"], start="2018-01-01")Financial Services short interest · DMAA price history · Who owns DMAA · All short interest